Protein classification typically uses structural, sequence or functional similarity. here we introduce an orthogonal method that organizes proteins by ligand similarity, focusing on the class A G-protein-coupled receptor (GPcr) protein family. comparing a ligand-based dendrogram to a sequence-based one, we identified GPcrs that were distantly linked by sequence but were neighbors by ligand similarity. experimental testing of the ligands predicted to link three of these new pairs confirmed the predicted association, with potencies ranging from low nanomolar to low micromolar. We also predicted hundreds of non-GPcrs closely related to GPcrs by ligand similarity and confirmed several cases experimentally. ligand similarities among these targets may reflect the conservation of identical ligands among unrelated receptors, which signal in different time domains. our method integrates these apparently disparate receptors into chemically coherent circuits and suggests which of these receptors may be targeted by individual ligands.
Protein classification typically uses structural, sequence or functional similarity. here we introduce an orthogonal method that organizes proteins by ligand similarity, focusing on the class A G-protein-coupled receptor (GPcr) protein family. comparing a ligand-based dendrogram to a sequence-based one, we identified GPcrs that were distantly linked by sequence but were neighbors by ligand similarity. experimental testing of the ligands predicted to link three of these new pairs confirmed the predicted association, with potencies ranging from low nanomolar to low micromolar. We also predicted hundreds of non-GPcrs closely related to GPcrs by ligand similarity and confirmed several cases experimentally. ligand similarities among these targets may reflect the conservation of identical ligands among unrelated receptors, which signal in different time domains. our method integrates these apparently disparate receptors into chemically coherent circuits and suggests which of these receptors may be targeted by individual ligands.
Since the molecular biology revolution, proteins have been related to each other bioinformatically by either sequence or structural similarities 1, 2 . When we seek to understand the ligand recognition of a protein or the specificity of a drug or a reagent, we typically consider those proteins that are related structurally, functionally 3 or by sequence 4 . Correspondingly, databases of protein families such as Pfam 5 and tools such as TRIBE-MCL 6 rely on multiple sequence alignments and machine learning to classify protein families.
Ligand recognition, however, does not always respect such molecular biology metrics. For instance, acetylcholine and serotonin signal through both GPCRs and ion channels, which are unrelated by sequence or structure. Both ligands are also recognized by specific transporters, which, in turn, are unrelated to GPCRs or to ion channels. In addition, drugs such as alosetron that target the ionotropic serotonin receptors (HTR3) also modulate the metabotropic serotonin receptors (such as HTR2B and HTR4) 7, 8 ; serotonergic GPCR-targeting drugs also modulate the serotonin transporter 9 . Ligands that modulate bile acid nuclear hormone receptor (NR1H4) also modulate the G protein-coupled A pharmacological organization of G protein-coupled receptors Henry Lin 1,3 , Maria F Sassano 2,3 , Bryan L Roth 2 & Brian K Shoichet 1 bile acid receptor (GPBAR1) 10 . Inhibitors of enzymes, from reverse transcriptases to kinases to proteases, can also modulate GPCRs and nuclear hormone receptors 9, [11] [12] [13] .
We thus wondered how a quantitative ligand-based organization of pharmacological targets might differ from the more familiar sequence-and structure-based approaches. It is easy, after all, to build a narrative with a few selected cases, such as acetylcholine and serotonin, but to understand whether a ligand-based relationship among targets will substantially differ from a sequence-based one, the two schemes must be compared globally and quantitatively. Because sequence and structure comparisons are restricted to targets within a single, evolutionarily related target family, we focused our attention on class A (rhodopsin-like) GPCRs. This is a large protein family, represented by about 700 genes in the human genome 14 , and a substantial number have annotated ligands, making it a good case in which to investigate this approach.
Here we addressed the following questions. How different is a sequence-based organization of the class A GPCRs from one based on ligand similarity? Do the differences explain nonobvious aspects of target pharmacology and drug discovery? Can we use the ligand-based organization prospectively, to predict and test new associations among previously unrelated targets? Although we and others [15] [16] [17] have used ligand-based metrics to predict the activities of individual drugs against off-targets, this is, to our knowledge, the first effort to compare pharmacological relationships across an entire family of targets. The associations that emerged from our global comparison were unexpected: some GPCRs that were distant by sequence identity became neighbors by ligand similarity, whereas others that were neighbors by sequence were pushed far apart by the dissimilarity of their ligand sets. The ligand-based target similarities also suggested new associations among receptors that were predicted and demonstrated in this study to share ligands, when these receptors have never been known to share ligands before. Because these associations are based on ligand similarities, they may be expanded to explore the polypharmacology between GPCRs and non-GPCRs, which are wholly unrelated by sequence and structure. An emergent property of these associations is that they recapitulate the activities of the cognate primary messengers, which also cross major target boundaries. This may reflect relationships in the time domain of molecular signaling, where ligand chemistry, not receptor sequence, is conserved.
results calculating ligand-and sequence-based dendrograms
The ChEMBL database, which annotates ligands to targets on the basis of literature reports, contains 146 class A GPCRs, each with at least six ligands 18 . On average each GPCR had 608 ligands, with a median of 380. Whereas this list captured only a minority of the roughly 700 class A GPCR members 14 , all of the major subfamilies were included, such as the biogenic amine receptors, the peptide receptors, the lipid-activated GPCRs, and receptors responding to protein ligands.
We organized these GPCRs by both sequence and ligand similarity. To focus on the part of the sequence most implicated in ligand binding, we used only those residues previously mapped to 1 of 43 orthosteric sites 19 . Sequence distances between any pair of targets were measured using the unweighted pair group method with arithmetic mean (UPGMA) algorithm 20 and rendered using FigTree (http://tree.bio.ed.ac.uk/software/figtree/) ( Fig. 1a) ; notwithstanding the focus on sequence identity in the binding site, the relationships that emerge resemble those based on dendrograms using full receptor sequence identity (such as with http://gpcr.scripps.edu/). For receptor association by ligand similarity, ligands were represented by topological fingerprints, which are bit strings that reflect the presence or absence of chemotypes and their chemical environment in the ligand. The similarity of these fingerprints was compared for all pairs of molecules in each ligand set for each pair of receptors, and the overall similarity of these sets was compared to an expected random similarity using machinery drawn from the sequence algorithm basic local alignment search tool (BLAST). An expectation value (E-value) for ligand-set relationships can be calculated using the similarity ensemble approach (SEA; Online Methods) 11, 21 . Ligand-based dendrograms, too, were calculated using FigTree, with the distance between pairs of GPCRs quantified by the cosine angle of their SEA E-values ( Fig. 1b) .
comparing the ligand-and sequence-based dendrograms
In the sequence-based dendrogram (Fig. 1a) , the relationships among the GPCRs were generally as expected. The biogenic amine receptors, including the adrenergic, dopaminergic and serotonergic GPCRs, largely clustered together, as did peptidic receptors, such as the chemokines and melanocortins, and the lipid-responding GPCRs. At a finer resolution, some peculiar divergences and associations began to appear. For instance, the cysteinyl leukotriene and leukotriene B4 receptors were separated not only from the other lipid-recognizing GPCRs but also from a b each other, even though they are a part of the same 5-lipoxygenase pathway involved in airway inflammation. Compared to the sequence-based organization, the ligand-based dendrogram ( Fig. 1b) was substantially rearranged. Notably, the muscarinic receptors shifted away from the other biogenic amine GPCRs and toward the chemokine receptors, with which they share little orthosteric site sequence identity (9%-21% identity across all subtypes). Equally notable, the β-adrenergic receptors separated from the α-adrenergic receptors and other biogenic amine GPCRs, moving closer to the cannabinoid lipid receptors and melatonin receptors. Other rearrangements, though covering just as much distance, seem easier to reconcile with the biology they control. The cysteinyl leukotriene and leukotriene B4 receptors were much closer to each other than they were by sequence-based organization, and they clustered with other lipid GPCRs, consistent with their roles in the same leukotriene inflammatory pathway.
Though these rearrangements seem superficially perplexing, their basis may be grasped by comparing the ligands that bind to these targets. Many GPCRs that are dissimilar by orthosteric site sequence bind similar ligands, to the point where exactly the same npg ligands are sometimes shared between them ( Supplementary  Table 1 ). For example, the opioid and somatostatin receptors shifted closer to the biogenic amine receptors in the ligandbased dendrogram. Despite their sequence differences, these peptidic receptors often bind aminergic molecules. The SSTR5 somatostatin 5 receptor and the HRH1 histamine H1 receptor, for instance, share only 33% sequence identity in their binding sites, even though their ligand sets resemble one another (E-value of 9.9 × 10 −8 ). Indeed, the two receptors are modulated by several identical ligands 22 ( Supplementary Table 1 ).
Conversely, some receptors, such as those in the muscarinic, β-adrenergic and chemokine families, separated from apparently cognate GPCRs. On the basis of ligand similarity, the muscarinic receptors moved closer to peptidic GPCRs, such as neuropeptide Y and chemokine receptors, and to lipid GPCRs, such as sphingosine phosphate and prostaglandin receptors; and they move away from the biogenic amine receptors. Thus, although the CHRM1 muscarinic acetylcholine receptor M1 and the MCHR1 melanincontaining hormone receptor 1 share only 26% sequence identity in the binding site, their SEA E-value was 8.3 × 10 −7 and they share several submicromolar ligands 23 (Supplementary Table 1) . The muscarinics share few ligands, and little ligand-set similarity, with most bioaminergic receptors. The separation of the βand α-adrenergics is explained by the divergence of their ligand sets. . 1) . Boldface targets have known ligands that bind to both the GPCR and non-GPCR targets. Links that share known messengers are labeled in black in parentheses.
npg
The two classes of receptors share adrenaline and noradrenaline as primary messengers and have sequence identities ranging from 49% to 63%, but once past the small catecholamines, their ligands diverge: the β-adrenergic ligands largely resemble isoproterenol, whereas the α-adrenergic antagonists vary widely, often characterized by larger compounds with disparate scaffolds. The chemokine receptors, which form an essentially contiguous family by sequence, are split into two groups on the basis of ligand similarity. One group, characterized by CXCR4, CCR1, CCR2 and CCR5, moved closer to the biogenic amine receptors, whereas CCR3, CCR8 and CXCR3 moved closer to the muscarinics and the neuropeptide Y receptors. For instance, though CCR5 and the CHRM2 muscarinic acetylcholine receptor M2 share only 16% sequence identity in the binding site, they share over 30 antagonists in several different ligand series ( Supplementary Table 1 ).
testing new associations from the ligand-based dendrogram
We asked whether the new associations could predict cross-talk between targets not formerly known to share ligands. Many of the new neighbors in the ligand-based dendrogram shared not even a single ligand, neither in ChEMBL nor in the literature, but nevertheless were highly related by the SEA E-values of their ligand lists. One such was the link between the κ opioid receptor (OPRK) and the 5-HT 2B serotonin receptor ligands (HTR2B), which resemble each other with a SEA E-value of 9.9 × 10 −8 though their sites share only 28% sequence identity. A SEA screen of the ZINC database 24 suggested that compound 1 ( Table 1 ) was similar to both the OPRK and HTR2B ligands. Upon in vitro testing, we found that compound 1 had an inhibition constant (K i ) of 0.9 µM to HTR2B and 1.0 µM to OPRK (Fig. 2 and Table 1 ). We note that after these experiments were concluded, another series of compounds were found by some of us, in an unrelated project, that also inhibited both targets. The chemical series that did so is unrelated to that described here 25 .
Although there are several known examples of ligand crosstalk between peptide and bioamine GPCRs, there are considerably fewer between peptide-and lipid-recognizing GPCRs. We therefore found notable the association between the NPY5R neuropeptide Y receptor 5 and CNR2 cannabinoid receptor 2. Though their binding sites share only 7% identity, they have a SEA E-value of 1.1 × 10 −9 . A particular CNR2 agonist, compound 2, resembled NPY5R ligands and was commercially available ( Table 1) . Compound 2 was found to bind to NPY5R with a halfmaximal inhibitory concentration (IC 50 ) of 190 nM (K i = 8.5 nM), similar to its CNR2 potency (effective concentration for half-maximum response (EC 50 ) = 140 nM) 26 . NPY5R was also linked to the MTNR1B melatonin receptor 1B, in yet another GPCR subclade, with a SEA E-value of 5.3 × 10 −13 . Here, too, we found a particular MTNR1B agonist (EC 50 = 14 µM), compound 3 ( Table 1) , that we measured to antagonize NPY5R with a K i of 1.9 µM.
extending the ligand dendrogram to non-GPcrs
We next asked how many of the GPCRs were strongly related by ligand similarity to a sequence-unrelated target. Interrogating all of the ChEMBL ligand sets, we found that there were ligand sets of 485 non-GPCRs that resembled at least one GPCR ligand set in our dendrogram with an E-value of 1 × 10 −10 or better (lower). Similarity values ranged from this level, for the ligand sets of the EDG7 lysophosphatidic acid GPCR and the enzyme arachidonate 12-lipoxygenase (LOX12), to 3 × 10 −314 for the ligand sets of the neurotensin 1 (NTSR1) GPCR and sortilin (SORT). These non-GPCR targets covered most protein families including ion channels, enzymes, kinases and glycoproteins. Indeed, there were so many non-GPCR-to-GPCR links that, for the sake of dendrogram clarity, we show only up to two for any given GPCR (Fig. 3) .
Here again, many highly-related pairs shared no single ligand between them, and for a few we predicted and tested ligands that would bind to both targets. We started with CXCR2 and casein . 4) . We also searched for a compound that could inhibit a GPCR and an enzyme in the same pathway. One such link was found between the α 2 -adrenergic receptors and their downstream phospholipase D1 and D2 (PLD1 and PLD2) enzymes 27 . Compound 5, a known phospholipase inhibitor, was tested against three α 2 -adrenergic receptor subtypes and had a K i of 556 nM to the α 2C subtype (Table 2 and Fig. 4) .
Finally, we sought targets implicated not only in the same pathway but also in a similar clinical indication. Among these were the cannabinoid receptors and the enzyme epoxide hydrolase 2 (HYES), whose ligand sets have an E-value of 1.3 × 10 −18 . Intriguingly, both proteins are cardioprotectant targets and both are in the endocannabinoid pathway (epoxide hydrolase 2 deactivates epoxidated endocanniboids) 28 . We identified compound 6, an HYES inhibitor, as a potential CNR2 cannabinoid receptor 2 ligand; on testing, we found that this molecule had K i values of 3.6 and 2.3 µM against CNR1 and CNR2, respectively ( Table 2 and Fig. 4) .
discussion
Relationships among targets are typically visualized by sequencebased family trees, and it is common to infer from these trees both on-and off-target pharmacology 29 . A key observation from this study was that when GPCRs were compared by ligand similarity, the arborization of the family tree changed dramatically. Targets that were neighbors by sequence were separated, whereas targets that were distant by sequence became neighbors. The predicted and confirmed cross-activity of ligands against the κ opioid and serotonin receptors, the cannabinoid and neuropeptide Y receptors and the neuropeptide Y and melatonin receptors were particularly unexpected. These pairs of targets not only share little residue identity in their orthosteric sites-from 7% to 28%-but also cross target boundaries among the GPCRs: from peptide to biogenic amine, lipid to peptide, and peptide to neutral small molecule. More startling still is the observation that many non-GPCRs strongly resembled GPCRs by ligand similarity (Fig. 3 and Table 2 ). Although some of this undoubtedly reflects the conservatism of medicinal chemistry, it is impossible to look at the penumbra of non-GPCRs that are strongly associated with GPCRs based on ligand similarity (Fig. 3) without wondering whether a more basic principle might be at work.
As sequence similarities reflect the action of evolution on proteins, the ligand-based dendrograms may reflect the chemical pressures against which the receptors have evolved. Many primary signaling molecules themselves target receptors unrelated by sequence or structure. For instance, serotonin modulates both the HTR3 receptor, an ion channel, and the HTR1-2,4-7 receptors, which are GPCRs. Acetylcholine targets the nicotinic receptors (ion channels) and the muscarinic receptors (GPCRs). Glutamate and GABA both signal ionotropically and metabotropically. Leukotriene B4 activates GPCRs and the nuclear hormone PPARs. Estrogen binds not only to its eponymous nuclear hormone receptor but also to GPR30 (Supplementary Table 2) 30 .
The promiscuity of primary signaling molecules reflects two constraints in biological signaling. First, cells respond to signals in multiple time domains: the millisecond, the second to minute, and the hour to day. To achieve these temporal resolutions, they will often use ion channels, GPCRs and nuclear hormone receptors, respectively. Second, these responses are evoked by a small repertoire of chemical messengers; once the machinery to synthesize, degrade and regulate molecules such as serotonin, acetylcholine and estrogen is created, it is costly to change and becomes fixed 31 . On the other hand, it is relatively easy for evolution to repurpose an ion channel to recognize serotonin or acetylcholine, or a GPCR to recognize glutamate. Thus, we hypothesize that the ability of receptors across major sequence and fold boundaries to recognize related ligands, which is captured in the ligand-based dendrograms, may reflect a chemo-evolutionary constraint in molecular signaling. If this is true, then probe and drug polypharmacology is neither epiphenomenal nor capricious but rather reflects the evolution of signaling relationships in the time domain. Pragmatically, the associations among unrelated targets, revealed in the ligand-based dendrograms, may suggest joint targets for a single ligand. Known examples are drugs that bind to both ionotropic and metabotropic serotonin receptors, such as alosetron, or that bind to both muscarinic receptors and acetylcholinesterase, such as gallamine triethiodide (Flaxedil; Fig. 3 ). Our discovery that compound 6 modulates both cannabinoid GPCRs and epoxide hydrolase 2 is consistent with a role for this enzyme in the degradation and signal termination of the endocannabinoids 28 .
Several weaknesses in this approach merit airing. Most prominently, a ligand-based view remains inference based: targets for which no ligands are known are invisible to it, and even when ligands are known, they can never be known perfectly, unlike the protein sequence. Mechanically, SEA remains imperfect: here, as npg previously 7, 12, 32 , the method had a 50% false-positive rate, with 6 of 12 predictions falsified by experiment ( Supplementary Table 3 ). Pharmacologically, finding a ligand to modulate both a GPCR and an enzyme in vitro does not guarantee intracellular enzyme inhibition in vivo, though GPCR activity of an enzyme inhibitor may be more likely. Also, we do not currently distinguish among agonists and antagonists, nor even between allosteric and orthosteric ligands; the conflation of these for a single receptor weakens the signal on which SEA operates. And in some protein families, such as the kinases, ligand-based and sequence-based dendrograms may resemble each other more closely than do those of the GPCRs because the binding site environments are more similar and the proteins bind a single or closely related native ligand. These cautions should not obscure the central observation from this study: a systematic and comprehensive ligand-based receptor organization differs startlingly from the more familiar sequencebased view. At least one other chemoinformatic approach, using only partially overlapping ligands and GPCRs, results in a dendrogram with receptor associations and disassociations that resemble those observed here 29 . Pragmatically, ligand-based organizations of receptors offer a guide to off-target effects of small-molecule tools and therapeutic molecules that is orthogonal to, but sometimes as illuminating as, the sequence-based view. More broadly, the association of 485 non-GPCRs with GPCRs by ligand similarity suggests a model for polypharmacology that reflects the roles of primary messengers in cellular signaling. A virtue of this model is that it leads naturally to testable hypotheses, articulated through the very molecules that are the basis of the ligandbased organization.
methods
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper. nAture methods online methods Sequences and structural alignment. The initial transmembrane sequence alignments were downloaded and filtered for human sequences only. The 43 binding site residues described in ref. 19 were then extracted for all human sequences, with sequence alignments maintained.
Annotated ligands. The ligands and affinity data were downloaded from ChEMBL (v.7) and filtered by their binding affinity values to create sets of ligands for targets if their IC 50 , K d , K i or EC 50 values were 10 µM or less. Ligands were also filtered by molecular weight (under 700 Da), nitrogen count (fewer than eight) and oxygen count (fewer than eight) to remove large molecules and peptides. The ChEMBL database does not explicitly differentiate between agonists and antagonists for its ligands, and here we combined both into the same ligand set for each GPCR without differentiating their functional activity. We assembled 146 human GPCR sets and 2,090 non-GPCR protein sets that each contained at least five annotated ligands, and these were used for comparisons by SEA.
Protein similarity calculations.
Binding site sequence alignments were used to calculate relative distances between all 146 GPCRs that had ligand sets associated with them. The UPGMA algorithm was used in MEGA 3.1 (ref. 33) to produce the pairwise distance matrix between all GPCRs. Similarities ranged from just 5% to 88% identity in the binding sites, with an average of 23%.
The ligand sets were also used to calculate relative distances between all 146 GPCRs by using SEA 11 to obtain E-values between each pair of GPCRs. Each ligand was broken down into molecular fingerprints; here extended connectivity fingerprints (ECFPs) 34 were used. Briefly, ECFPs are circular topological fingerprints that represent molecular structures by small atom neighborhoods or substructures, along with their physical chemical properties. The similarity between any pair of bit strings (molecules) is quantified by the bits they share in common divided by the total number of bits, via the Tanimoto coefficient (Tc) 35 . The sum of all Tc values over a certain cutoff between all the molecules in the two target-ligand sets is then calculated and compared to what we would expect for two sets of ligands, with the same set size, randomly drawn from ChEMBL. The ratio of the observed sum of Tc values to that expected at random is divided by the s.d. of the random similarity to give a z score; when plotted against an extreme value distribution, this gives an expectation value (E-value). The E-values were then logged and used to calculate the pairwise cosine angle. The cosine angle was used as the distance metric, as E-values are not necessarily completely correlative with similarity; rather, we used them as more of a binary measure, with E-values less (better) than 1 × 10 −5 taken as significant and anything greater (worse) taken as insignificant. Therefore, using the cosine angle, the magnitude of the E-value is not overweighed such that E-values of 1 × 10 −300 and 1 × 10 −20 are treated about the same because they are both significant E-values. Similarities between GPCRs and non-GPCRs were calculated in the same way, with the annotated ligand sets used as surrogates for the protein in the calculation of SEA E-values. The two lowest E-values between each GPCR and the non-GPCRs were retained.
Dendrograms. Using the similarity distance matrices of the binding site sequences and ligand sets, dendrograms were constructed using FigTree. The distance matrices were inputted in Newick format, and a radial tree format was used for the layout. The spread was increased to better distinguish the proteins that are highly similar to each other. Nodes were further expanded out in Adobe Illustrator for legibility and color coded according to the chemistry of their endogenous ligands: for example, peptide, bioamine, lipid and so forth. The two non-GPCRs with the lowest E-values were drawn on using Adobe Illustrator and linked to their respective GPCRs. The non-GPCRs in boldface represent those non-GPCRs that have a known shared ligand with the GPCR.
Radioligand competition binding assays. Standard techniques were used 36 at the NIMH Psychoactive Drug Screening Program.
CXCR2 b-arrestin recruitment Tango assay. Recruitment of βarrestin to agonist-stimulated CXCR2 receptors was performed using a previously described 'Tango'-type assay that monitors receptor activation using a reporter gene signal 37 . Briefly, HTLA cells stably expressing β-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 10-cm dishes in DMEM containing 10% FBS and transiently transfected (via calcium phosphate) with 10 µg of a CXCR2-V 2 -TCS-tTA construct. The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner; 15,000 cells per well, 50 µL per well) in DMEM containing 1% dialyzed FBS and incubated overnight at 37 °C. The following day, cells were challenged with 10 µL per well of reference agonist or CXCR2 test ligand (CXCL6 and CXCL8) at evenly distributed concentrations that ranged from 6 pM to 60 µM prepared in HBSS, 20 mM HEPES, pH 7.4, and 6% DMSO (final ligand concentrations were 1 pM-10 µM; final DMSO concentration was 1%). After 18 h, the medium was removed and replaced with 1× BriteGlo reagent (Promega), and luminescence per well was read using a TriLux plate reader (1 s per well). Data were normalized to vehicle (0%) and reference compound (100%) controls and regressed using the sigmoidal dose-response function built into GraphPad Prism 5.0.
